A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

Clinical trial NCT04959266 · TERMINATED

Trial details

NCT number: NCT04959266
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumours

Start date: 2021-06-28
Primary completion: 2022-06-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.